Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
SEC Accession No. 0001753926-25-001868
Filing Date
2025-12-11
Accepted
2025-12-11 10:14:49
Documents
3
Period of Report
2025-12-11

Document Format Files

Seq Description Document Type Size
1 6-K/A g085041_6ka.htm 6-K/A 29918
2 EXHIBIT 99.1 g085041_ex99-1.htm EX-99.1 29402
3 GRAPHIC image_001.jpg GRAPHIC 6766
  Complete submission text file 0001753926-25-001868.txt   70018
Mailing Address 55 UNIVERSITY AVENUE, SUITE 1003 TORONTO Ontario, Canada M5J 2H7
Business Address 55 UNIVERSITY AVENUE, SUITE 1003 TORONTO Ontario, Canada M5J 2H7 (416) 854-8884
Quantum Biopharma Ltd. (Filer) CIK: 0001771885 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 6-K/A | Act: 34 | File No.: 001-39152 | Film No.: 251563796
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)